Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 4.9B | 4.7B | 5.5B | 4.8B |
Cost of revenue | 3.3B | 3.1B | 3.7B | 3.2B |
Gross profit | 1.6B | 1.5B | 1.8B | 1.6B |
Operating expense | ||||
Research & development | 238M | 221M | 237M | 228M |
Selling general and admin | 414M | 426M | 461M | 411M |
Other operating expenses | — | — | — | — |
Operating income | 901M | 877M | 1.1B | 984M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 421M | 378M | 418M | 394M |
Other income expense | -239M | -139M | -216M | -188M |
Pretax income | 241M | 360M | 454M | 402M |
Tax provision | 89M | 75M | 95M | 77M |
Net income | 176M | 310M | 438M | 402M |
Basic EPS | 0.1 | 0.2 | 0.3 | 0.3 |
Diluted EPS | 0.1 | 0.2 | 0.3 | 0.3 |
Basic average shares | 1.2B | 1.3B | 1.3B | 1.3B |
Diluted average shares | 1.3B | 1.3B | 1.3B | 1.3B |
EBITDA | 837M | 905M | 1.1B | 975M |
Net income from continuing op. | 176M | 243M | 438M | 402M |
Minority interests | -3M | -4M | -5M | -1M |
Preferred stock dividends | — | — | — | — |